Get the Stockscreener App
8.00
0.00%
0.00
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Zynex Inc stock is traded at $8.00, with a volume of 25,562.
It is up +0.00% in the last 24 hours and up +1.27% over the past month.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
See More
Previous Close:
$8.00
Open:
$8
24h Volume:
25,562
Relative Volume:
0.24
Market Cap:
$254.76M
Revenue:
$184.32M
Net Income/Loss:
$9.73M
P/E Ratio:
17.39
EPS:
0.46
Net Cash Flow:
$16.55M
1W Performance:
-10.31%
1M Performance:
+1.27%
6M Performance:
-27.27%
1Y Performance:
-12.62%
1-Day Range:
$7.97
$8.20
1-Week Range:
$7.97
$9.04
52-Week Range:
$7.15
$13.77
Zynex Inc Stock (ZYXI) Company Profile
Name
Zynex Inc
Sector
Industry
Phone
(800)-495-6670
Address
9655 MAROON CIRCLE, ENGLEWOOD, CO
Zynex Inc Stock (ZYXI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-16-23 | Initiated | RBC Capital Mkts | Outperform |
| Jan-06-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-28-22 | Reiterated | B. Riley Securities | Buy |
| Jul-16-21 | Upgrade | B. Riley Securities | Neutral → Buy |
| Mar-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Feb-26-21 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-28-21 | Downgrade | Northland Capital | Outperform → Market Perform |
| Sep-14-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-09-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-29-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jul-20-20 | Initiated | Piper Sandler | Overweight |
| Jul-13-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jul-10-20 | Reiterated | H.C. Wainwright | Neutral |
| Jun-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-19-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-01-20 | Initiated | Northland Capital | Outperform |
| Sep-23-19 | Initiated | H.C. Wainwright | Buy |
View All
Zynex Inc Stock (ZYXI) Latest News
Zynex CFO Daniel Moorhead sells $85,900 in stock By Investing.com - Investing.com Australia
Insider Sale: CFO Daniel Moorhead Sells 10,000 Shares of Zynex I - GuruFocus.com
Zynex, Inc. (NASDAQ:ZYXI) CFO Daniel J. Moorhead Sells 10,000 Shares - MarketBeat
Zynex CFO Daniel Moorhead sells $85,900 in stock - Investing.com
Zynex, Inc. (NASDAQ:ZYXI) CEO Sells $17,260.00 in Stock - MarketBeat
Zynex CEO Thomas Sandgaard sells $52,740 in stock - Investing.com India
Insider Sale: Thomas Sandgaard Sells Shares of Zynex Inc (ZYXI) - GuruFocus.com
Zynex CEO Thomas Sandgaard sells $52,740 in stock By Investing.com - Investing.com Australia
Zynex's (NASDAQ:ZYXI) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Zynex (ZYXI) Stock Forecast and Price Target 2024 - MarketBeat
Zynex Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Zynex (NASDAQ:ZYXI) Seems To Use Debt Quite Sensibly - Simply Wall St
Zynex, Inc. (NASDAQ:ZYXI) Q3 2024 Earnings Call Transcript - Insider Monkey
Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates - MSN
How To Trade (ZYXI) - Stock Traders Daily
Earnings call: Zynex reports steady Q3 growth, plans for future expansion - Investing.com Nigeria
Earnings call: Zynex reports steady Q3 growth, plans for future expansion By Investing.com - Investing.com South Africa
Zynex (NASDAQ:ZYXI) Posts Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Zynex (NASDAQ:ZYXI) Price Target Raised to $17.00 - MarketBeat
Zynex shares target increased, buy rating held on strong Q3 results - Investing.com
Zynex Inc (ZYXI) Q3 2024 Earnings Call Highlights: Navigating Gr - GuruFocus.com
Zynex Inc (ZYXI) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience. - Proactive Investors USA
Zynex (NASDAQ:ZYXI) Updates FY 2024 Earnings Guidance - MarketBeat
Zynex sees pain management orders increase in Q3 following FDA approval - Proactive Investors UK
Zynex Reports Third Quarter 2024 Financial Results - PR Newswire
Sales, strategy, and saving lives: A conversation with Zynex CEO Thomas Sandgaard - Proactive Investors USA
Preview: Zynex's Earnings - Benzinga
Pain Management Devices Market Report 2024 and Company Benchmarking for Abbott, Medtronic, Zynex Medical, Boston Scientific and OMRON Healthcare - Yahoo Finance
Womens Health Rehabilitation Products Market to Witness Huge - openPR
Zynex, Inc. (NASD: ZYXI) Wins 2023 National Top Workplaces Award in the Manufacturing Industry Category - GuruFocus.com
Zynex Sets Third Quarter 2024 Earnings Call - Lelezard
AQR Capital Management LLC Sells 67,148 Shares of Zynex, Inc. (NASDAQ:ZYXI) - MarketBeat
Millennium Management LLC Acquires 118,615 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World
Zynex, Inc.: 2025 Looks Like A Brighter Year (NASDAQ:ZYXI) - Seeking Alpha
Zynex price target lowered to $11 from $12 at RBC Capital - Yahoo Finance
Royal Bank of Canada Cuts Zynex (NASDAQ:ZYXI) Price Target to $11.00 - MarketBeat
(ZYXI) Technical Data - Stock Traders Daily
Zynex, Inc. (NASDAQ:ZYXI) Shares Bought by Renaissance Technologies LLC - MarketBeat
Electrotherapy System Market 2024-2031: Key Trends, Growth - openPR
Investors in Zynex (NASDAQ:ZYXI) have unfortunately lost 22% over the last five years - Yahoo Finance
Zynex's SWOT analysis: pain management firm's stock faces growth hurdles By Investing.com - Investing.com Canada
Zynex's SWOT analysis: pain management firm's stock faces growth hurdles - Investing.com
Handheld Electric Muscle Stimulator Market Recent Industry Innovations – Zynex, Zimmer, OMRON Corporation, BioMedical Life Systems – Cauverynews - cauverynews.tv
Muscle Stimulator Market Size, Share, Growth Insights - openPR
Affinity Asset Advisors LLC Purchases New Stake in Zymeworks Inc. (NYSE:ZYME) - MarketBeat
Vanguard Personalized Indexing Management LLC Raises Holdings in Jefferies Financial Group Inc. (NYSE:JEF) - Defense World
HITE Hedge Asset Management LLC Makes New Investment in ZEEKR Intelligent Technology Holding Limited (NYSE:ZK) - MarketBeat
Zymeworks price target raised to $12 from $10 at H.C. Wainwright - TipRanks
ProShare Advisors LLC Trims Stake in Kennedy-Wilson Holdings, Inc. (NYSE:KW) - MarketBeat
Rhumbline Advisers Acquires 7,210 Shares of Zymeworks Inc. (NYSE:ZYME) - Defense World
Zynex Inc Stock (ZYXI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zynex Inc Stock (ZYXI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Oct 30 '24 |
Sale |
8.92 |
2,000 |
17,840 |
14,625,350 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Oct 31 '24 |
Sale |
8.82 |
2,000 |
17,640 |
14,623,350 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 01 '24 |
Sale |
8.63 |
2,000 |
17,260 |
14,621,350 |
9.80%
2.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):